Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 9, Issue 10, Pages 575-583
Publisher
Springer Nature
Online
2013-08-13
DOI
10.1038/nrendo.2013.154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- WNT1 Mutations in Families Affected by Moderately Severe and Progressive Recessive Osteogenesis Imperfecta
- (2013) Shawna M. Pyott et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in WNT1 Cause Different Forms of Bone Fragility
- (2013) Katharina Keupp et al. AMERICAN JOURNAL OF HUMAN GENETICS
- In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma
- (2013) Samantha Pozzi et al. BONE
- Serum sclerostin levels in men with idiopathic osteoporosis
- (2013) B Lapauw et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mutations in WNT1 are a cause of osteogenesis imperfecta
- (2013) Somayyeh Fahiminiya et al. JOURNAL OF MEDICAL GENETICS
- WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
- (2013) Christine M. Laine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recessively Inherited Forms of Osteogenesis Imperfecta
- (2012) Peter H. Byers et al. Annual Review of Genetics
- Novel SOST gene mutation in a sclerosteosis patient and her parents
- (2012) Sanjay Kumar Bhadada et al. BONE
- Effects of PTH on osteocyte function
- (2012) Teresita Bellido et al. BONE
- Future Directions in Osteoporosis Therapeutics
- (2012) Henry Bone ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Bisphosphonates in the Treatment of Osteoporosis
- (2012) Dima L. Diab et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Osteocyte RANKL: New insights into the control of bone remodeling
- (2012) Jinhu Xiong et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels
- (2012) Sandra Jastrzebski et al. JOURNAL OF BONE AND MINERAL RESEARCH
- β-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice
- (2012) Jianquan Chen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- TREM2 and -Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis
- (2012) K. Otero et al. JOURNAL OF IMMUNOLOGY
- Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
- (2012) Kazuhiro Maeda et al. NATURE MEDICINE
- Targeted deletion of Sost distal enhancer increases bone formation and bone mass
- (2012) N. M. Collette et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading
- (2011) Xiaolin Tu et al. BONE
- Update on Wnt signaling in bone cell biology and bone disease
- (2011) David G. Monroe et al. GENE
- Determinants of serum sclerostin in healthy pre- and postmenopausal women
- (2011) Mohammed-Salleh M Ardawi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling
- (2011) Stefano Zanotti et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by -Catenin
- (2011) W. Wei et al. MOLECULAR AND CELLULAR BIOLOGY
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- LRP4 Mutations Alter Wnt/β-Catenin Signaling and Cause Limb and Kidney Malformations in Cenani-Lenz Syndrome
- (2010) Yun Li et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls
- (2010) A H van Lierop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function
- (2010) Elke Piters et al. HUMAN MUTATION
- Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Functionin Vitroand Increase Bone Massin Vivo
- (2010) Helmut Glantschnig et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The amazing osteocyte
- (2010) Lynda F Bonewald JOURNAL OF BONE AND MINERAL RESEARCH
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
- (2010) Faryal S. Mirza et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Update in New Anabolic Therapies for Osteoporosis
- (2010) Ernesto Canalis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Application of Target Information and Preclinical Pharmacokinetic/Pharmacodynamic Modeling in Predicting Clinical Doses of a Dickkopf-1 Antibody for Osteoporosis
- (2010) A. M. Betts et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Osteocyte Wnt/ -Catenin Signaling Is Required for Normal Bone Homeostasis
- (2010) I. Kramer et al. MOLECULAR AND CELLULAR BIOLOGY
- WNT5A Regulates Chondrocyte Differentiation through Differential Use of the CaN/NFAT and IKK/NF-κB Pathways
- (2010) Elizabeth W. Bradley et al. MOLECULAR ENDOCRINOLOGY
- Mechanical signals as anabolic agents in bone
- (2010) Engin Ozcivici et al. Nature Reviews Rheumatology
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation
- (2009) Peter V.N. Bodine et al. BONE
- Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis
- (2009) C. Surmann-Schmitt et al. JOURNAL OF CELL SCIENCE
- Growth factor control of bone mass
- (2009) Ernesto Canalis JOURNAL OF CELLULAR BIOCHEMISTRY
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies
- (2009) Fernando Rivadeneira et al. NATURE GENETICS
- Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
- (2009) Hong Y. Choi et al. PLoS One
- Wnt signaling: A win for bone
- (2008) Elke Piters et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The role of Dickkopf-1 in bone development, homeostasis, and disease
- (2008) J. J. Pinzone et al. BLOOD
- The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome
- (2008) R. Raz et al. DEVELOPMENT
- Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss
- (2008) Feng-Sheng Wang et al. ENDOCRINOLOGY
- On the Interpretation of Rat Carcinogenicity Studies for Human PTH(1-34) and Human PTH(1-84)
- (2008) Armen H Tashjian et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in Bone
- (2008) Bart O Williams et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt signaling and skeletal development
- (2007) Fei Liu et al. CELLULAR SIGNALLING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now